• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊在 COVID-19 封锁限制措施实施前后,对住院儿童中呼吸道合胞病毒的流行病学研究。

Epidemiology of respiratory syncytial virus in hospitalized children before, during, and after the COVID-19 lockdown restriction measures in Greece.

机构信息

School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Epidemiol Infect. 2024 May 13;152:e94. doi: 10.1017/S0950268824000724.

DOI:10.1017/S0950268824000724
PMID:38736253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11736444/
Abstract

The COVID-19 pandemic modified the epidemiology and the transmission of respiratory syncytial virus (RSV). We collected data on RSV positivity and incidence from children hospitalized in the largest tertiary paediatric hospital in Greece before (2018-2020, period A), during (2020-2021, period B), and after (2021-2023, period C) the COVID-19 lockdown. A total of 9,508 children were tested for RSV. RSV positivity (%) was 17.6% (552/3,134) for period A, 2.1% (13/629) for period B, and 13.4% (772/5,745) for period C (p < 0.001). The mean age (±SD) of RSV-positive children among the three periods was A: 5.9(±9.3), B: 13.6 (±25.3), and C: 16.7 (±28.6) months (p < 0.001). The peak of RSV epidemiology was shifted from January-March (period A) to October-December (period C). RSV in-hospital incidence per 1,000 hospitalizations in paediatric departments was A:16.7, B:1.0, and C:28.1 (p < 0.001), and the incidence in the intensive care unit was A: 17.3, B: 0.6, and C: 26.6 (p < 0.001). A decrease in RSV incidence was observed during the COVID-19 lockdown period, whereas a significant increase was observed after the lockdown. A change in epidemiological patterns was identified after the end of the lockdown, with an earlier seasonal peak and an age shift of increased RSV incidence in older children.

摘要

COVID-19 大流行改变了呼吸道合胞病毒 (RSV) 的流行病学和传播方式。我们收集了希腊最大的三级儿科医院住院儿童的 RSV 阳性率和发病率数据,这些数据来自 COVID-19 封锁之前(2018-2020 年,A 期)、期间(2020-2021 年,B 期)和之后(2021-2023 年,C 期)。共有 9508 名儿童接受了 RSV 检测。A 期 RSV 阳性率(%)为 17.6%(552/3134),B 期为 2.1%(13/629),C 期为 13.4%(772/5745)(p<0.001)。三个时期 RSV 阳性儿童的平均年龄(±SD)分别为 A 期:5.9(±9.3),B 期:13.6(±25.3)和 C 期:16.7(±28.6)个月(p<0.001)。RSV 流行病学的高峰从 1 月至 3 月(A 期)转移到 10 月至 12 月(C 期)。儿科病房每 1000 例住院的 RSV 院内发病率分别为 A 期:16.7,B 期:1.0,C 期:28.1(p<0.001),重症监护病房为 A 期:17.3,B 期:0.6,C 期:26.6(p<0.001)。在 COVID-19 封锁期间,RSV 发病率下降,而封锁后发病率显著上升。封锁结束后,我们发现了流行病学模式的变化,季节性高峰提前,年龄较大的儿童 RSV 发病率上升。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/11736444/f51b3f2c10c6/S0950268824000724_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/11736444/02ec72cd7e35/S0950268824000724_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/11736444/4c0e85ba4374/S0950268824000724_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/11736444/f51b3f2c10c6/S0950268824000724_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/11736444/02ec72cd7e35/S0950268824000724_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/11736444/4c0e85ba4374/S0950268824000724_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ac/11736444/f51b3f2c10c6/S0950268824000724_fig3.jpg

相似文献

1
Epidemiology of respiratory syncytial virus in hospitalized children before, during, and after the COVID-19 lockdown restriction measures in Greece.希腊在 COVID-19 封锁限制措施实施前后,对住院儿童中呼吸道合胞病毒的流行病学研究。
Epidemiol Infect. 2024 May 13;152:e94. doi: 10.1017/S0950268824000724.
2
Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.新型冠状病毒肺炎非药物干预措施对住院儿童呼吸道合胞病毒感染的影响
Influenza Other Respir Viruses. 2024 Apr;18(4):e13291. doi: 10.1111/irv.13291.
3
Clinical Phenotype of Respiratory Syncytial Virus Bronchiolitis before and during the Coronavirus Disease 2019 Pandemic.呼吸道合胞病毒毛细支气管炎在 2019 冠状病毒病大流行前后的临床表型。
Am J Perinatol. 2024 Mar;41(4):515-521. doi: 10.1055/s-0042-1759602. Epub 2022 Dec 21.
4
Epidemiology and viral loads of respiratory syncytial virus in hospitalized children prior to and during COVID-19 pandemic in Hangzhou, China.中国杭州 COVID-19 大流行前后住院儿童呼吸道合胞病毒的流行病学和病毒载量。
J Med Virol. 2024 Aug;96(8):e29855. doi: 10.1002/jmv.29855.
5
Respiratory Syncytial Virus Epidemiology in Argentina: From COVID-19 Pandemic to the Maternal Immunization Strategy.阿根廷呼吸道合胞病毒流行病学:从新冠疫情到母体免疫策略
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S23-S26. doi: 10.1097/INF.0000000000004597. Epub 2025 Feb 14.
6
Comparison of characteristics of children hospitalized for respiratory syncytial virus infection during the pre- and post-COVID-19 eras: a multicenter retrospective study.比较 COVID-19 前后时期因呼吸道合胞病毒感染住院的儿童的特征:一项多中心回顾性研究。
BMC Infect Dis. 2024 Sep 19;24(1):1009. doi: 10.1186/s12879-024-09783-2.
7
Recent trends in hospitalizations for respiratory syncytial virus after the COVID-19 pandemic and before routine immunization: Seasonality and severity updates from the 2023/2024 season in Tuscany, Italy.2019年冠状病毒病大流行后至常规免疫接种前呼吸道合胞病毒住院治疗的近期趋势:意大利托斯卡纳2023/2024季节的季节性和严重程度更新
Int J Infect Dis. 2025 May;154:107879. doi: 10.1016/j.ijid.2025.107879. Epub 2025 Mar 13.
8
Epidemiology of Respiratory Syncytial Virus Hospitalizations in Poland: An Analysis from 2015 to 2023 Covering the Entire Polish Population of Children Aged under Five Years.波兰呼吸道合胞病毒住院流行病学:2015 年至 2023 年涵盖所有 5 岁以下儿童的波兰整个人群分析。
Viruses. 2024 Apr 29;16(5):704. doi: 10.3390/v16050704.
9
Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study.在 COVID-19 大流行期间呼吸道合胞病毒的季节性和严重程度:一项动态队列研究。
Int J Infect Dis. 2024 Nov;148:107231. doi: 10.1016/j.ijid.2024.107231. Epub 2024 Sep 1.
10
Clinical and epidemiological characteristics of respiratory syncytial virus, SARS-CoV-2 and influenza paediatric viral respiratory infections in southwest Saudi Arabia.沙特阿拉伯西南部呼吸道合胞病毒、SARS-CoV-2和流感小儿病毒性呼吸道感染的临床及流行病学特征
Ann Med. 2025 Dec;57(1):2445791. doi: 10.1080/07853890.2024.2445791. Epub 2024 Dec 24.

引用本文的文献

1
Impact of COVID-19 on the epidemiology of severe sinogenic and otogenic infections and their intracranial complications.2019冠状病毒病对严重鼻窦源性和耳源性感染及其颅内并发症流行病学的影响。
Eur J Pediatr. 2025 May 24;184(6):359. doi: 10.1007/s00431-025-06188-4.

本文引用的文献

1
Efficacy and safety of respiratory syncytial virus vaccination during pregnancy to prevent lower respiratory tract illness in newborns and infants: a systematic review and meta-analysis of randomized controlled trials.孕期接种呼吸道合胞病毒疫苗预防新生儿和婴儿下呼吸道疾病的有效性和安全性:一项随机对照试验的系统评价和荟萃分析
Front Pediatr. 2024 Jan 31;11:1260740. doi: 10.3389/fped.2023.1260740. eCollection 2023.
2
Respiratory Syncytial Virus and Influenza During the COVID-19 Pandemic: A Two-center Experience.COVID-19 大流行期间的呼吸道合胞病毒和流感:一项两中心经验。
Pediatr Infect Dis J. 2024 May 1;43(5):410-414. doi: 10.1097/INF.0000000000004260. Epub 2024 Jan 22.
3
Respiratory syncytial virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational study.
加拿大不列颠哥伦比亚省2019冠状病毒病大流行之前及期间呼吸道合胞病毒的流行病学与临床严重程度:一项回顾性观察研究
Lancet Reg Health Am. 2023 Aug 30;25:100582. doi: 10.1016/j.lana.2023.100582. eCollection 2023 Sep.
4
Why has the epidemiology of RSV changed during the COVID-19 pandemic?在新冠疫情期间,呼吸道合胞病毒的流行病学为何发生了变化?
EClinicalMedicine. 2023 Jul 6;61:102089. doi: 10.1016/j.eclinm.2023.102089. eCollection 2023 Jul.
5
RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future.呼吸道合胞病毒在新冠疫情期间:负担、流行病学变化及其对未来的影响。
Pediatr Pulmonol. 2023 Jun;58(6):1631-1639. doi: 10.1002/ppul.26370. Epub 2023 Mar 3.
6
The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review.2019年冠状病毒病大流行对呼吸道合胞病毒感染的影响:一项叙述性综述
Infect Drug Resist. 2023 Jan 30;16:661-675. doi: 10.2147/IDR.S396434. eCollection 2023.
7
Decline of RSV-specific antibodies during the COVID-19 pandemic.新冠疫情期间呼吸道合胞病毒特异性抗体的下降。
Lancet Infect Dis. 2023 Jan;23(1):23-25. doi: 10.1016/S1473-3099(22)00763-0. Epub 2022 Dec 1.
8
Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.希腊儿童及其父母的抗 SARS-CoV-2 抗体血清阳性率。
Eur J Pediatr. 2023 Jan;182(1):439-449. doi: 10.1007/s00431-022-04681-8. Epub 2022 Nov 16.
9
Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis.高收入国家 60 岁及以上成年人呼吸道合胞病毒疾病负担:系统文献回顾和荟萃分析。
Influenza Other Respir Viruses. 2023 Jan;17(1):e13031. doi: 10.1111/irv.13031. Epub 2022 Nov 11.
10
Increased use of high-flow nasal cannulas after the pandemic in bronchiolitis: a more severe disease or a changed physician's attitude?疫情后毛细支气管炎中高流量鼻导管的使用增加:是疾病更严重了还是医生态度改变了?
Eur J Pediatr. 2022 Nov;181(11):3931-3936. doi: 10.1007/s00431-022-04601-w. Epub 2022 Sep 9.